Potential targets for pancreatic cancer immunotherapeutics

Lindzy F Dodson1, William G Hawkins, Peter Goedegebuure

  • 1Washington University School of Medicine, Department of Surgery, Saint Louis, MO 63110, USA. lfriend@wustl.edu

Immunotherapy
|April 6, 2011
PubMed

Insights

Pancreatic cancer vaccines show promise in animal models but limited success in patients. Strategies to overcome immune suppression are crucial for improving pancreatic cancer treatment efficacy.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Pancreatic adenocarcinoma is a deadly cancer with poor survival rates.
  • Antigen identification has led to vaccine strategies for pancreatic cancer.
  • Clinical trials show limited success, possibly due to immune suppression.

Purpose of the Study:

  • To review recent advances in pancreatic cancer antigen vaccination.
  • To discuss identified mechanisms of immune suppression in pancreatic cancer.
  • To propose strategies for enhancing vaccine clinical efficacy.

Main Methods:

  • Review of current literature on pancreatic cancer vaccines.
  • Analysis of immune suppression mechanisms in pancreatic cancer.
  • Synthesis of findings to propose future research directions.

Main Results:

  • Promising results from animal tumor models for pancreatic cancer vaccines.
  • Limited clinical success of current pancreatic cancer vaccine strategies.
  • Emerging understanding of immune suppressive mechanisms hindering treatment.

Conclusions:

  • Overcoming immune suppression is key to improving pancreatic cancer vaccine efficacy.
  • Further research is needed to optimize vaccination strategies for pancreatic cancer patients.
  • Targeting immune suppressive mechanisms may enhance antitumor responses.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...